Hikma receives FDA approval for its generic Vascepa® |
May 22, 2020 | May 2020 Bond Updates |
LONDON, May 22, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, today announces that its wholly owned U.S. subsidiary Hikma Pharmaceuticals USA Inc. has received approval from the US Food and Drug Administration (FDA) for its... |
View more at: https://www.prnewswire.com:443/news-releases/hikma-receives-fda-approval-for-its-generic-vascepa-301064061.html |
Related News |